VOLUNTARY ANNOUNCEMENT MARKETING AUTHORIZATION APPLICATION FOR LECANKITUG INJECTION ACCEPTED FOR REVIEW BY CHINA’S NATIONAL MEDICAL PRODUCTS ADMINISTRATION
(I) RE-ELECTION OF THE BOARD OF DIRECTORS; (II) ELECTION OF EMPLOYEE REPRESENTATIVE DIIRECTOR; (III) CHANGES IN THE COMPOSITION OF BOARD COMMITTEES; AND (IV) APPOINTMENT OF SENIOR MANAGEMENT ANISECURITIES AFFAIRS REPRESENTATIVE
POLL RESULTS OF THE ANNUAL GENERAL MEETING FOR THE YEAR 2025, THE 2026 FIRST CLASS MEETING OF A SHAREHOLDERS AND THE 2026 FIRST CLASS MEETING OF H SHAREHOLDERS HELD ON 29 MAY 2026
